KEITH MCDANIEL: Open Payments
NPI 1205454451 · WILLIAMSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$499 in 37 payments from 11 companies in 2025. Trend: 2023 $192 · 2024 $311 · 2025 $499
Food & beverage: $499
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $140 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| PFIZER INC. | 3 | $43 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $20 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
Products named: CAPLYTA, QULIPTA, UBRELVY, LEQVIO, NURTEC ODT, Qelbree, REXULTI, VYEPTI.
Industry payments across KY — which companies pay providers there.
